AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMBBiotechnology
+$0.25 today
- Market cap
- $286.62M
- Beta
- 2.62
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$1.28
Volume 0.13M
Average 0.14M
AGMB Effect of Forex Changes
Change in reported cash caused by exchange-rate movements on foreign-currency balances.
AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB
Effect of Forex Changes · Q4 FY2024 · quarter ended Dec 2024
Effect of forex changes of €0 in Q4 FY2024
Q4 FY2024 effect of forex changes was €0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Effect of Forex Changes history
Currency unavailable · from the cash flow
No Effect of Forex Changes data reported for this period type.
Effect of Forex Changes vs competitors
How AGMB compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $70K USD | +119.6% | — | 0.9% |
| LTM Mar 2026 | $51K USD | +176.1% | +111.0% | — | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | — | — | — | — | — |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding AGMB) | — | +147.8% | +111.0% | 0.0% | |
Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMB
Intrinsic Alpha fair value
Locked
Current Price
$5.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.